Susquehanna International Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.34M Sell
201,270
-224,200
-53% -$4.84M ﹤0.01% 1447
2025
Q1
$7.07M Sell
425,470
-498,015
-54% -$8.27M ﹤0.01% 871
2024
Q4
$16.9M Buy
923,485
+249,366
+37% +$4.58M ﹤0.01% 502
2024
Q3
$10.4M Buy
674,119
+344,551
+105% +$5.3M ﹤0.01% 629
2024
Q2
$5.36M Buy
329,568
+156,465
+90% +$2.54M ﹤0.01% 977
2024
Q1
$3.2M Sell
173,103
-202,160
-54% -$3.74M ﹤0.01% 1354
2023
Q4
$11.7M Buy
375,263
+52,883
+16% +$1.66M ﹤0.01% 616
2023
Q3
$6.72M Buy
322,380
+263,917
+451% +$5.5M ﹤0.01% 915
2023
Q2
$1.4M Sell
58,463
-171,797
-75% -$4.11M ﹤0.01% 2302
2023
Q1
$4.33M Buy
230,260
+151,522
+192% +$2.85M ﹤0.01% 1205
2022
Q4
$1.25M Sell
78,738
-112,852
-59% -$1.8M ﹤0.01% 2079
2022
Q3
$3.13M Buy
191,590
+4,677
+3% +$76.5K ﹤0.01% 1224
2022
Q2
$2.63M Buy
186,913
+75,430
+68% +$1.06M ﹤0.01% 1402
2022
Q1
$2.7M Sell
111,483
-280,637
-72% -$6.8M ﹤0.01% 1704
2021
Q4
$9.15M Buy
392,120
+78,180
+25% +$1.82M ﹤0.01% 829
2021
Q3
$5.22M Sell
313,940
-218,034
-41% -$3.62M ﹤0.01% 1130
2021
Q2
$13M Buy
531,974
+290,358
+120% +$7.08M ﹤0.01% 699
2021
Q1
$6.23M Buy
241,616
+72,997
+43% +$1.88M ﹤0.01% 1069
2020
Q4
$9.01M Sell
168,619
-53,303
-24% -$2.85M ﹤0.01% 702
2020
Q3
$9.15M Buy
221,922
+64,549
+41% +$2.66M ﹤0.01% 568
2020
Q2
$7.63M Buy
157,373
+81,940
+109% +$3.97M ﹤0.01% 630
2020
Q1
$3.19M Sell
75,433
-227,086
-75% -$9.59M ﹤0.01% 954
2019
Q4
$12.9M Buy
302,519
+43,147
+17% +$1.85M ﹤0.01% 436
2019
Q3
$9.34M Buy
259,372
+68,670
+36% +$2.47M ﹤0.01% 441
2019
Q2
$5.1M Buy
190,702
+137,607
+259% +$3.68M ﹤0.01% 670
2019
Q1
$1.43M Sell
53,095
-74,013
-58% -$1.99M ﹤0.01% 1025
2018
Q4
$2.06M Buy
+127,108
New +$2.06M ﹤0.01% 940
2018
Q3
Hold
0
3262
2018
Q2
Sell
-264,800
Closed -$5.95M 3570
2018
Q1
$5.95M Sell
264,800
-145,986
-36% -$3.28M ﹤0.01% 443
2017
Q4
$12.4M Sell
410,786
-96,151
-19% -$2.9M ﹤0.01% 295
2017
Q3
$19.1M Buy
506,937
+227,619
+81% +$8.57M 0.01% 192
2017
Q2
$7.79M Sell
279,318
-287,107
-51% -$8.01M ﹤0.01% 376
2017
Q1
$19.5M Buy
566,425
+195,665
+53% +$6.73M 0.01% 163
2016
Q4
$10.7M Buy
370,760
+72,103
+24% +$2.08M 0.01% 252
2016
Q3
$9.5M Sell
298,657
-181,346
-38% -$5.77M ﹤0.01% 222
2016
Q2
$15.6M Buy
480,003
+165,006
+52% +$5.36M 0.01% 151
2016
Q1
$8.81M Sell
314,997
-94,150
-23% -$2.63M ﹤0.01% 388
2015
Q4
$14.6M Sell
409,147
-157,932
-28% -$5.63M 0.01% 328
2015
Q3
$18.8M Buy
567,079
+22,202
+4% +$734K 0.01% 292
2015
Q2
$22.8M Buy
544,877
+118,122
+28% +$4.95M 0.01% 288
2015
Q1
$13.9M Sell
426,755
-589,046
-58% -$19.2M 0.01% 364
2014
Q4
$32.3M Buy
1,015,801
+390,565
+62% +$12.4M 0.01% 208
2014
Q3
$15.5M Sell
625,236
-122,192
-16% -$3.03M 0.01% 412
2014
Q2
$16.9M Buy
747,428
+165,635
+28% +$3.74M 0.01% 392
2014
Q1
$14.2M Sell
581,793
-264,080
-31% -$6.43M 0.01% 413
2013
Q4
$21.1M Buy
845,873
+11,389
+1% +$285K 0.01% 327
2013
Q3
$22.9M Buy
834,484
+219,958
+36% +$6.04M 0.01% 250
2013
Q2
$11.2M Buy
+614,526
New +$11.2M 0.01% 477